Literature DB >> 26327707

CARBapenem utilizatiON evaluation in a large community hospital (CARBON): A Quality Improvement Study.

Jesse Janssen1, Angus Kinkade2, Damen Man3.   

Abstract

Entities:  

Year:  2015        PMID： 26327707      PMCID： PMC4552234          DOI： 10.4212/cjhp.v68i4.1473

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  10 in total

Review 1.  Appropriate use of the carbapenems.

Authors:  A J Brink; C Feldman; D C Grolman; D Muckart; J Pretorius; G A Richards; M Senekal; W Sieling
Journal:  S Afr Med J       Date:  2004-10

2.  The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America.

Authors:  Brad Spellberg; Robert Guidos; David Gilbert; John Bradley; Helen W Boucher; W Michael Scheld; John G Bartlett; John Edwards
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

3.  Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.

Authors:  Milena McLaughlin; M Renee Advincula; Michael Malczynski; Chao Qi; Maureen Bolon; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

4.  A multicenter study measuring appropriateness of carbapenem use.

Authors:  Gregory Weston; Jesse T Jacob; Susan Ray; Jay Varkey; Robert P Gaynes
Journal:  Infect Control Hosp Epidemiol       Date:  2013-10-23       Impact factor: 3.254

5.  Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Authors:  Thomas Tängdén; Otto Cars; Asa Melhus; Elisabeth Löwdin
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

6.  Seasonal variation in the epidemiology of sepsis.

Authors:  Pajman A Danai; Sumita Sinha; Marc Moss; Michael J Haber; Greg S Martin
Journal:  Crit Care Med       Date:  2007-02       Impact factor: 7.598

Review 7.  Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.

Authors:  Enrico Maria Trecarichi; Roberto Cauda; Mario Tumbarello
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

8.  Appropriate use of carbapenems in the Besançon university hospital.

Authors:  F Jary; J-D Kaiser; T Henon; J Leroy; I Patry; G Blasco; S Limat
Journal:  Med Mal Infect       Date:  2012-10-06       Impact factor: 2.152

Review 9.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883

10.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790
  10 in total
  2 in total

1.  Prescribing patterns and comparison of culture versus empiric-based selection of meropenem in cats and dogs in a veterinary teaching hospital (2011-2018).

Authors:  Lillian M Cousto; J Scott Weese; Shane W Bateman
Journal:  Can Vet J       Date:  2020-03       Impact factor: 1.008

2.  Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study.

Authors:  Jeffrey R Strich; Sarah Warner; Yi Ling Lai; Cumhur Y Demirkale; John H Powers; Robert L Danner; Sameer S Kadri
Journal:  Lancet Infect Dis       Date:  2020-06-04       Impact factor: 71.421
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.